James Lovett

Chief Executive Officer

James is driven to help clients deliver medical advances, to develop Myonex team members, and to lead Myonex to continued success. Before joining Myonex in 2017 as Chief Operating Officer, James was SVP of Covance, where he led three business units, was General Counsel and served on the Executive Committee. He was named Myonex CEO in 2019. James also has served on the Boards of Directors of FoodChain ID, the Wistar Institute, BioClinica Inc., and the National Association for Biomedical Research, as well as Chair of the Policy Committee of ACRO. James is a graduate of Northwestern University and Harvard Law School.